The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://news.sky.com/story/woodford-investors-in-line-for-225m-from-biotech-sale-12000717
Just a mention
The company has a lot of pipelines including a candidate for phase 3 . The market cap should be at least £150 million imho.
I was looking at this today at 20p ish but wanted to keep some money aside for another short term trade that I didn’t even end up doing!
He who hesitates and all that!
Dear god! I was looking at this today what a miss! Well good luck to you all
A placing at 17p, and it ends up 50p, I`ve never
seen anything like it!
directors paid over 60 pence more than 2 years ago !!!!!
I sold out of this between 20 and 33 parmx and so am gutted too ..
oh well.. good luck to the long and strongs here.. and nice to see some doing well here ....
Needs a breather
RSI AND STOC ! HOWEVER IF THERE IS NEWS 1 POUND WILL BE HIT FAST -Always rated it but this is a turn up for the books
I for one didn't sell yesterday and was a little bit kicking myself in the morning but after 1 hour of trading when I saw that buying pressure when sp was down 14% I realised that something may have been afoot.
PARMXZ I FEEL FOR YOU i done that before hope you make it up .IF ur long term destiny pharma i
I feel WILL be very special
I am kicking myself. I always had this share on my priority list and had some invested. Unfortunately, I sold it yesterday hoping to invest back next week.
40.50p +16p (68.75%)
Look at the Nasdag 59% UP, they like the deal also, but no share for us at 17p placing
3.12 USD +1.16 (59.18%)
I posted about this drug last week. Maybe this week also.
https://www.mereobiopharma.com/news-and-events/press-releases/2020/mereo-and-oncologie-enter-global-licensing-agreement-for-navicixizumab/mereo-and-oncologie-enter-global-licensing-agreement-for-navicixizumab/
Navicixizamub babe a median of 7.3 months of progress free of symptoms for sufferers of ovarian cancers that had been treated with every other drug know to man
It was fast tracked by the FDA, because the patients had nothing to lose and everything to gain. Just think what it can do for patients, if they had it before it had progressed so far?
This is in addition to the brittle bone drug they are moving along.
DYOR
Just letting it ride. If you are you to invest that much they would not need to invest much more to clear the sellers that have dragged the price down over the last few months
Agree, this isn`t normal after a fundraising!
Than meets the eye we must have other news coming if so this will hit a pound
Waw I didn’t expect that after 14% down this morning, fully funded till 2022 now
And we are off! 34 being paid
Now rising and 30P being paid.
Private placement completed raising $70.0 million (£56.0 million) before expenses.New Ordinary Shares and Convertible Loan Notes issued provide the Company with certainty of receiving the full amount of the proceeds of the private placement at closing.89,144,630 new Ordinary Shares have been placed at the Issue Price to raise $19.4 million (£15.5 million) before expenses, utilising share authorities granted on 2 June 2016 and 19 June 2019 and issued on a non-pre-emptive basis.Convertible Loan Notes have been issued in an aggregate principal amount $50.6 million (£40.5 million) to complete the Fundraising.Price per Placing Share of 17.4 pence.Investors have received conditional Warrants to subscribe for further Ordinary Shares in an aggregate number equal to 50 per cent of both the new Ordinary Shares purchased by that investor in the Placing and the Ordinary Shares issuable upon conversion of the Convertible Loan Notes purchased by that investor in the Fundraising, with an exercise price of 34.8 pence per Warrant. The Warrants will be capable of being exercised for a period of 3 years after the date on which the Resolutions are passed.SVB Leerink acted as the exclusive placement agent to the Company in connection with the Fundraising.
MIGHT DRIFT but if your long no worries
BRILLIANT NEWS placement raise money at 17.4p happy with that fully funded
3.16% up on NASDAQ yesterday.
American Association of Cancer Research (AACR) Virtual Annual Meeting II on June 22-24, 2020.